Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Michael S Hearne. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Michael S Hearne a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:AUPH / Aurinia Pharmaceuticals Inc. Chief Financial Officer 116.144
US:LJPC / La Jolla Pharmaceutical Co. Chief Financial Officer 0
US:ODT / Odonate Therapeutics Inc Chief Financial Officer 12.767.435
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Michael S Hearne. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior AUPH / Aurinia Pharmaceuticals Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în AUPH / Aurinia Pharmaceuticals Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Vânzări din interior AUPH / Aurinia Pharmaceuticals Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în AUPH / Aurinia Pharmaceuticals Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Achiziții din interior ODTC / Odonate, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în AUPH / Aurinia Pharmaceuticals Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
2020-12-23 ODT TANG KEVIN C 63.354 15,4282 63.354 15,4282 977.438 47 27.39 757.828 77,53
2020-12-23 ODT TANG KEVIN C 75.784 15,7080 75.784 15,7080 1.190.415
2020-12-22 ODT TANG KEVIN C 37.856 14,5754 37.856 14,5754 551.766
2020-12-22 ODT TANG KEVIN C 36.646 15,1673 36.646 15,1673 555.821
2020-12-21 ODT TANG KEVIN C 62.144 14,5753 62.144 14,5753 905.767
2020-09-29 ODT TANG KEVIN C 10.882 13,8484 10.882 13,8484 150.698
2020-09-28 ODT TANG KEVIN C 100.000 13,0571 100.000 13,0571 1.305.710
2020-08-28 ODT TANG KEVIN C 1.052.631 14,2500 1.052.631 14,2500 14.999.992
2019-06-26 ODT TANG KEVIN C 769.231 26,0000 769.231 26,0000 20.000.006
2019-06-18 ODT TANG KEVIN C 21.350 26,8862 21.350 26,8862 574.020
2019-06-17 ODT TANG KEVIN C 1.905 26,1999 1.905 26,1999 49.911
2019-06-17 ODT TANG KEVIN C 8.137 26,9535 8.137 26,9535 219.321
2019-06-14 ODT TANG KEVIN C 18.608 24,9513 18.608 24,9513 464.294
2019-06-07 ODT TANG KEVIN C 20.000 26,3110 20.000 26,3110 526.220
2019-06-06 ODT TANG KEVIN C 6.308 27,5579 6.308 27,5579 173.835
2019-06-06 ODT TANG KEVIN C 41.312 27,7052 41.312 27,7052 1.144.557
2019-06-06 ODT TANG KEVIN C 8.688 27,9517 8.688 27,9517 242.844
2019-06-05 ODT TANG KEVIN C 9.972 25,1382 9.972 25,1382 250.678
2019-06-05 ODT TANG KEVIN C 29.484 26,1112 29.484 26,1112 769.863
2019-06-04 ODT TANG KEVIN C 34.714 24,9156 34.714 24,9156 864.920
2019-06-04 ODT TANG KEVIN C 4.236 24,9886 4.236 24,9886 105.852
2019-06-03 ODT TANG KEVIN C 7.859 22,1605 7.859 22,1605 174.159
2019-06-03 ODT TANG KEVIN C 7.427 22,8551 7.427 22,8551 169.745
2019-03-08 ODT TANG KEVIN C 22.863 18,1039 22.863 18,1039 413.909
2019-03-08 ODT TANG KEVIN C 77.137 18,9361 77.137 18,9361 1.460.674
2019-03-07 ODT TANG KEVIN C 19.036 16,5627 19.036 16,5627 315.288
2019-03-07 ODT TANG KEVIN C 964 17,1526 964 17,1526 16.535
2019-03-07 ODT TANG KEVIN C 20.000 17,4955 20.000 17,4955 349.910
2018-12-31 ODT TANG KEVIN C 10.000 13,4201 10.000 13,4201 134.201
2018-12-31 ODT TANG KEVIN C 10.000 13,5070 10.000 13,5070 135.070
2018-12-31 ODT TANG KEVIN C 10.000 13,9866 10.000 13,9866 139.866
2018-12-31 ODT TANG KEVIN C 3.700 13,9978 3.700 13,9978 51.792
2018-12-28 ODT TANG KEVIN C 10.000 12,0394 10.000 12,0394 120.394
2018-12-28 ODT TANG KEVIN C 10.000 13,3469 10.000 13,3469 133.469
2018-12-27 ODT TANG KEVIN C 10.000 12,0315 10.000 12,0315 120.315
2018-12-26 ODT TANG KEVIN C 10.000 12,3966 10.000 12,3966 123.966
2018-12-26 ODT TANG KEVIN C 10.000 12,3384 10.000 12,3384 123.384
2018-12-26 ODT TANG KEVIN C 10.000 12,0937 10.000 12,0937 120.937
2018-12-21 ODT TANG KEVIN C 10.000 12,2731 10.000 12,2731 122.731
2018-12-21 ODT TANG KEVIN C 3.500 12,4364 3.500 12,4364 43.527
2018-12-21 ODT TANG KEVIN C 6.500 13,7799 6.500 13,7799 89.569
2018-12-20 ODT TANG KEVIN C 10.000 13,1742 10.000 13,1742 131.742
2018-12-18 ODT TANG KEVIN C 1.704 15,1770 1.704 15,1770 25.862
2018-12-18 ODT TANG KEVIN C 10.000 14,1327 10.000 14,1327 141.327
2018-12-17 ODT TANG KEVIN C 9.550 14,5070 9.550 14,5070 138.542
2018-12-17 ODT TANG KEVIN C 450 15,2000 450 15,2000 6.840
2018-12-17 ODT TANG KEVIN C 8.296 14,8542 8.296 14,8542 123.230
2018-12-14 ODT TANG KEVIN C 10.000 15,0838 10.000 15,0838 150.838
2018-12-12 ODT TANG KEVIN C 4.550 15,6522 4.550 15,6522 71.218
2018-12-12 ODT TANG KEVIN C 10.000 15,7728 10.000 15,7728 157.728
2018-12-11 ODT TANG KEVIN C 5.450 15,2528 5.450 15,2528 83.128
2018-12-07 ODT TANG KEVIN C 9.500 14,9780 9.500 14,9780 142.291
2018-12-06 ODT TANG KEVIN C 10.000 14,6243 10.000 14,6243 146.243
2018-12-06 ODT TANG KEVIN C 500 14,6598 500 14,6598 7.330

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

ODTC / Odonate, Inc. Insider Trades
Vânzări din interior ODTC / Odonate, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în AUPH / Aurinia Pharmaceuticals Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2021-11-19 ODT TANG KEVIN C 365.289 1,9161 365.289 1,9161 699.930 49 1.0900 -301.765 -43,11
2021-11-18 ODT TANG KEVIN C 212.423 1,9708 212.423 1,9708 418.643
2021-11-18 ODT TANG KEVIN C 500.000 1,8812 500.000 1,8812 940.600
2021-11-18 ODT TANG KEVIN C 381.842 1,8925 381.842 1,8925 722.636
2021-11-17 ODT TANG KEVIN C 468.849 2,6583 468.849 2,6583 1.246.341
2021-11-17 ODT TANG KEVIN C 31.151 1,9941 31.151 1,9941 62.118
2021-11-17 ODT TANG KEVIN C 500.000 2,0161 500.000 2,0161 1.008.050
2021-11-17 ODT TANG KEVIN C 287.577 2,1985 287.577 2,1985 632.238

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

ODTC / Odonate, Inc. Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Michael S Hearne, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2026-05-20 2026-05-18 4 AUPH Aurinia Pharmaceuticals Inc.
Common Stock
A - Award 116.144 116.144
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9.607.934 0 -100,00 6,23 -59.857.429
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9.607.934 0 -100,00 6,23 -59.857.429
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
D - Sale to Issuer -10.186 0 -100,00 6,23 -63.459
2022-07-05 2022-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 236 10.186 2,37 2,71 640 27.619
2022-06-17 2022-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 236 9.950 2,43 2,72 642 27.064
2022-06-02 2022-05-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 189 9.714 1,98 3,41 644 33.110
2022-05-17 2022-05-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 188 188
2022-05-17 2022-05-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 188 9.525 2,01 3,41 641 32.466
2022-05-03 2022-04-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 185 185
2022-05-03 2022-04-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 185 9.337 2,02 3,47 642 32.381
2022-04-18 2022-04-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2022-04-18 2022-04-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 9.152 1,93 3,71 643 33.995
2022-04-04 2022-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 177 177
2022-04-04 2022-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 177 8.979 2,01 3,63 642 32.589
2022-03-17 2022-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 190 190
2022-03-17 2022-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 190 8.802 2,21 3,37 640 29.628
2022-03-02 2022-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 185 185
2022-03-02 2022-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 185 8.612 2,20 3,48 643 29.940
2022-02-17 2022-02-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2022-02-17 2022-02-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 8.427 2,05 3,79 641 31.947
2022-02-02 2022-01-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 1.675 1.675
2022-02-02 2022-01-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 1.675 8.258 25,44 3,94 6.592 32.499
2022-01-19 2022-01-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 148 148
2022-01-19 2022-01-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 148 6.583 2,30 4,18 619 27.530
2022-01-14 2022-01-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 78.552 78.552
2022-01-04 2021-12-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 157 157
2022-01-04 2021-12-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 157 6.435 2,50 3,92 615 25.216
2021-12-17 2021-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2021-12-17 2021-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 6.278 2,83 3,58 619 22.466
2021-12-02 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 186 186
2021-12-02 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 186 6.105 3,14 3,32 617 20.238
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -41.290 9.607.934 -0,43 3,66 -151.303 35.207.313
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -136.255 9.649.224 -1,39 3,76 -512.128 36.267.573
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -63.745 9.785.479 -0,65 3,95 -251.544 38.614.479
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -6.597 9.849.224 -0,07 3,95 -26.067 38.918.224
2021-12-01 2021-11-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -193.403 9.855.821 -1,92 4,10 -793.107 40.416.751
2021-11-19 2021-11-19 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -365.289 12.767.435 -2,78 1,92 -699.930 24.463.682
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -381.842 13.132.724 -2,83 1,89 -722.636 24.853.680
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500.000 13.514.566 -3,57 1,88 -940.600 25.423.602
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -212.423 14.014.566 -1,49 1,97 -418.643 27.619.907
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -287.577 14.226.989 -1,98 2,20 -632.238 31.278.035
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500.000 14.514.566 -3,33 2,02 -1.008.050 29.262.817
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -31.151 15.014.566 -0,21 1,99 -62.118 29.940.546
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -468.849 15.045.717 -3,02 2,66 -1.246.341 39.996.030
2021-11-17 2021-11-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 181 181
2021-11-17 2021-11-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 181 5.919 3,15 3,41 617 20.175
2021-11-02 2021-10-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 181 181
2021-11-02 2021-10-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 181 5.738 3,26 3,42 618 19.607
2021-10-19 2021-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 183 183
2021-10-19 2021-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 183 5.557 3,41 3,37 616 18.705
2021-10-04 2021-09-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 182 182
2021-10-04 2021-09-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 182 5.374 3,51 3,39 617 18.226
2021-09-17 2021-09-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 546 546
2021-09-17 2021-09-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 546 5.192 11,75 3,39 1.852 17.609
2021-08-03 2021-07-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 201 201
2021-08-03 2021-07-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 201 4.646 4,52 3,07 617 14.256
2021-07-19 2021-07-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 193 193
2021-07-19 2021-07-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 193 4.445 4,54 3,20 617 14.206
2021-07-02 2021-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 170 170
2021-07-02 2021-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 170 4.252 4,16 3,64 618 15.469
2021-06-17 2021-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 148 148
2021-06-17 2021-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 148 4.082 3,76 4,16 616 17.002
2021-06-02 2021-05-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2021-06-02 2021-05-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 3.934 4,49 3,66 618 14.379
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43.734 10.049.224 0,44 4,53 198.014 45.499.872
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 15.358 10.005.490 0,15 4,29 65.917 42.943.563
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 184.642 9.990.132 1,88 4,47 825.978 44.689.856
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.286 9.805.490 0,01 4,50 5.785 44.109.016
2021-05-26 2021-05-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 166.932 9.804.204 1,73 4,26 710.763 41.744.340
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 31.782 9.637.272 0,33 3,83 121.874 36.956.047
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 95.597 9.605.490 1,01 3,77 360.860 36.258.804
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 104.403 9.509.893 1,11 3,68 384.234 34.999.259
2021-05-18 2021-05-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 193 193
2021-05-18 2021-05-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 193 3.765 5,40 3,20 617 12.033
2021-05-04 2021-04-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 163 163
2021-05-04 2021-04-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 163 3.572 4,78 3,77 615 13.481
2021-04-19 2021-04-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2021-04-19 2021-04-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 3.835 4,72 3,55 615 13.626
2021-04-02 2021-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 172 172
2021-04-02 2021-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 172 3.662 4,93 3,60 620 13.198
2021-03-17 2021-03-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37 37
2021-03-17 2021-03-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 37 2.620 1,43 16,22 600 42.496
2021-03-17 2021-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 127 127
2021-03-17 2021-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 127 3.490 3,78 4,85 616 16.939
2021-03-02 2021-02-26 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 34 34
2021-03-02 2021-02-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 34 2.583 1,33 17,89 608 46.210
2021-03-02 2021-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 139 139
2021-03-02 2021-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 139 3.363 4,31 4,45 619 14.979
2021-02-18 2021-02-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 535 535
2021-02-18 2021-02-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 535 3.224 19,90 5,70 3.051 18.388
2021-02-17 2021-02-12 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 28 28
2021-02-17 2021-02-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 28 2.549 1,11 21,19 593 54.013
2021-02-02 2021-01-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 31 31
2021-02-02 2021-01-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 31 2.521 1,24 19,64 609 49.512
2021-02-02 2020-12-31 4/A LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 1.648 2.435 209,40 3,30 5.435 8.031
2021-02-02 2021-01-15 4/A LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 136 2.571 5,59 4,55 618 11.692
2021-02-02 2021-01-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 118 118
2021-02-02 2021-01-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 118 2.689 4,59 5,20 614 13.988
2021-01-20 2021-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 35 35
2021-01-20 2021-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 35 2.490 1,43 16,99 595 42.305
2021-01-20 2021-01-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 136 136
2021-01-20 2021-01-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 136 1.094 14,20 4,55 618 4.975
2021-01-05 2020-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 350 350
2021-01-05 2020-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 350 2.455 16,63 16,32 5.712 40.066
2021-01-05 2020-12-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 171 171
2021-01-05 2020-12-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 171 958 21,73 3,30 564 3.159
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 75.784 15.514.566 0,49 15,71 1.190.415 243.702.803
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 63.354 15.438.782 0,41 15,43 977.438 238.192.616
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 36.646 15.375.428 0,24 15,17 555.821 233.203.729
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 37.856 15.338.782 0,25 14,58 551.766 223.568.883
2020-12-23 2020-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 62.144 15.300.926 0,41 14,58 905.767 223.015.587
2020-12-17 2020-12-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43 43
2020-12-17 2020-12-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 43 2.105 2,09 12,91 555 27.176
2020-12-16 2020-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 147 147
2020-12-16 2020-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 147 787 22,97 3,82 562 3.010
2020-12-14 2020-12-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 52.191 52.191
2020-12-10 2020-12-08 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22.639 22.639
2020-12-02 2020-11-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 45 45
2020-12-02 2020-11-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 45 2.062 2,23 12,77 575 26.332
2020-12-02 2020-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 134 134
2020-12-02 2020-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 134 640 26,48 4,22 566 2.704
2020-11-17 2020-11-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 141 141
2020-11-17 2020-11-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 141 506 38,63 3,98 561 2.013
2020-11-17 2020-11-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 46 46
2020-11-17 2020-11-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 46 2.017 2,33 12,20 561 24.607
2020-11-05 2020-10-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 196 196
2020-11-05 2020-10-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 196 365 115,98 2,89 566 1.055
2020-11-03 2020-10-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 46 46
2020-11-03 2020-10-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 46 1.971 2,39 12,25 564 24.145
2020-10-19 2020-10-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2020-10-19 2020-10-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 1.925 2,23 13,35 561 25.699
2020-10-19 2020-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2020-10-19 2020-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 169 3,32 561 561
2020-10-02 2020-09-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50 50
2020-10-02 2020-09-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 50 1.883 2,73 11,42 571 21.504
2020-09-30 2020-09-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.882 15.238.782 0,07 13,85 150.698 211.032.749
2020-09-30 2020-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 100.000 15.227.900 0,66 13,06 1.305.710 198.832.213
2020-09-17 2020-09-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43 43
2020-09-17 2020-09-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 43 1.833 2,40 13,06 562 23.939
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 78.369 9.405.490 0,84 4,03 316.047 37.930.460
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 48.296 9.327.121 0,52 4,01 193.894 37.445.593
2020-09-09 2020-09-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 84.152 9.278.825 0,92 3,90 328.529 36.224.533
2020-09-09 2020-09-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 67.552 9.194.673 0,74 3,82 258.359 35.165.946
2020-09-02 2020-08-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2020-09-02 2020-08-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 1.790 2,40 13,73 577 24.577
2020-09-01 2020-08-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.052.631 15.127.900 7,48 14,25 14.999.992 215.572.575
2020-08-18 2020-08-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2020-08-18 2020-08-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.748 1,04 30,71 553 53.681
2020-08-14 2020-08-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 168.669 9.127.121 1,88 3,88 653.694 35.373.070
2020-08-14 2020-08-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 219.465 8.958.452 2,51 3,65 800.586 32.679.537
2020-08-14 2020-08-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43.513 8.738.987 0,50 3,47 150.820 30.290.203
2020-08-04 2020-07-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2020-08-04 2020-07-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.730 1,05 30,91 556 53.474
2020-07-17 2020-07-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2020-07-17 2020-07-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.712 1,00 34,99 595 59.903
2020-07-02 2020-06-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 15 15
2020-07-02 2020-06-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 15 1.695 0,89 35,99 540 61.003
2020-06-17 2020-06-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2020-06-17 2020-06-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.680 1,02 34,21 582 57.473
2020-06-04 2020-06-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 215.812 8.695.474 2,55 4,94 1.065.636 42.936.512
2020-06-04 2020-06-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 145.764 8.479.662 1,75 4,90 714.783 41.581.719
2020-06-04 2020-06-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 253.553 8.333.898 3,14 4,88 1.237.060 40.660.255
2020-06-03 2020-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 100.000 100.000
2020-06-02 2020-05-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2020-06-02 2020-05-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 1.663 2,46 27,77 1.111 46.182
2020-05-19 2020-05-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 47 47
2020-05-19 2020-05-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 47 1.623 2,98 24,00 1.128 38.952
2020-05-04 2020-04-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 47 47
2020-05-04 2020-04-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 47 1.576 3,07 23,93 1.125 37.714
2020-04-17 2020-04-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50 50
2020-04-17 2020-04-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 50 1.529 3,38 22,82 1.141 34.892
2020-04-02 2020-03-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 24 24
2020-04-02 2020-03-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 24 1.479 1,65 23,47 563 34.712
2020-03-17 2020-03-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2020-03-17 2020-03-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 1.455 2,03 19,59 568 28.503
2020-03-03 2020-02-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2020-03-03 2020-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.426 1,57 25,15 553 35.864
2020-02-19 2020-02-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2020-02-19 2020-02-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.404 1,52 26,73 561 37.529
2020-02-04 2020-01-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 23 23
2020-02-04 2020-01-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 23 1.383 1,69 24,82 571 34.326
2020-01-17 2020-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 24 24
2020-01-17 2020-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 24 1.360 1,80 23,15 556 31.484
2020-01-03 2019-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 20 20
2020-01-03 2019-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 20 1.336 1,52 27,58 552 36.847
2019-12-17 2019-12-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2019-12-17 2019-12-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.316 1,70 24,62 542 32.400
2019-12-12 2019-12-10 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 32.173 32.173
2019-12-03 2019-11-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-12-03 2019-11-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.294 1,49 29,22 555 37.811
2019-11-19 2019-11-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-11-19 2019-11-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.275 1,51 28,14 535 35.878
2019-11-04 2019-10-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2019-11-04 2019-10-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.256 1,70 27,00 567 33.912
2019-10-17 2019-10-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2019-10-17 2019-10-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.235 1,81 24,23 533 29.924
2019-10-02 2019-09-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 25 25
2019-10-02 2019-09-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 25 1.213 2,10 22,13 553 26.844
2019-09-17 2019-09-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 23 23
2019-09-17 2019-09-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 23 1.188 1,97 24,11 555 28.643
2019-09-04 2019-08-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2019-09-04 2019-08-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.165 1,84 26,19 550 30.511
2019-08-19 2019-08-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-08-19 2019-08-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.144 1,69 28,42 540 32.512
2019-08-02 2019-07-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 16 16
2019-08-02 2019-07-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 16 1.125 1,44 34,64 554 38.970
2019-07-17 2019-07-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2019-07-17 2019-07-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.109 1,65 29,89 538 33.148
2019-07-02 2019-06-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2019-07-02 2019-06-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.091 1,58 31,19 530 34.028
2019-06-28 2019-06-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 769.231 14.075.269 5,78 26,00 20.000.006 365.956.994
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 26 26
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 26 1.074 2,48 21,25 552 22.822
2019-06-18 2019-06-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 21.350 13.306.038 0,16 26,89 574.020 357.748.799
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.137 13.284.688 0,06 26,95 219.321 358.068.838
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.905 13.276.551 0,01 26,20 49.911 347.844.309
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 18.608 13.274.646 0,14 24,95 464.294 331.219.675
2019-06-10 2019-06-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20.000 13.256.038 0,15 26,31 526.220 348.779.616
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.688 13.236.038 0,07 27,95 242.844 369.969.763
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 41.312 13.227.350 0,31 27,71 1.144.557 366.466.377
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6.308 13.186.038 0,05 27,56 173.835 363.379.517
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 29.484 13.179.730 0,22 26,11 769.863 344.138.566
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.972 13.150.246 0,08 25,14 250.678 330.573.514
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4.236 13.140.274 0,03 24,99 105.852 328.357.051
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 34.714 13.136.038 0,26 24,92 864.920 327.292.268
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7.427 13.101.324 0,06 22,86 169.745 299.432.070
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7.859 13.093.897 0,06 22,16 174.159 290.167.304
2019-06-04 2019-05-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 30 30
2019-06-04 2019-05-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 30 1.048 2,95 18,27 548 19.147
2019-05-17 2019-05-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2019-05-17 2019-05-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 1.018 2,93 18,87 547 19.210
2019-05-02 2019-04-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 33 33
2019-05-02 2019-04-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 33 989 3,45 16,71 551 16.526
2019-04-17 2019-04-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 26 26
2019-04-17 2019-04-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 26 956 2,80 21,24 552 20.305
2019-04-02 2019-03-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2019-04-02 2019-03-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 930 3,22 18,79 545 17.475
2019-03-19 2019-03-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 27 27
2019-03-19 2019-03-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 27 901 3,09 20,19 545 18.191
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 77.137 13.086.038 0,59 18,94 1.460.674 247.798.524
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 22.863 13.008.901 0,18 18,10 413.909 235.511.843
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20.000 12.986.038 0,15 17,50 349.910 227.197.228
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 964 12.966.038 0,01 17,15 16.535 222.401.263
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 19.036 12.965.074 0,15 16,56 315.288 214.736.631
2019-03-04 2019-02-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 39 39
2019-03-04 2019-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 39 874 4,67 14,01 546 12.245
2019-02-20 2019-02-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 39 39
2019-02-20 2019-02-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 39 835 4,90 14,04 548 11.723
2019-02-04 2019-01-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 38 38
2019-02-04 2019-01-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 38 796 5,01 14,08 535 11.208
2019-01-17 2019-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2019-01-17 2019-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 758 5,57 13,85 554 10.498
2019-01-03 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 45.045 45.045
2019-01-03 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 45 718 6,69 11,97 539 8.594
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3.700 12.946.038 0,03 14,00 51.792 181.216.051
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.942.338 0,08 13,99 139.866 181.019.305
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.932.338 0,08 13,51 135.070 174.677.089
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.922.338 0,08 13,42 134.201 173.419.068
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.912.338 0,08 13,35 133.469 172.339.684
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.902.338 0,08 12,04 120.394 155.336.408
2018-12-31 2018-12-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.892.338 0,08 12,03 120.315 155.114.165
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.882.338 0,08 12,09 120.937 155.795.131
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.872.338 0,08 12,34 123.384 158.824.055
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.862.338 0,08 12,40 123.966 159.449.259
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6.500 12.852.338 0,05 13,78 89.569 177.103.932
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3.500 12.845.838 0,03 12,44 43.527 159.755.980
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.842.338 0,08 12,27 122.731 157.615.299
2018-12-26 2018-12-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.832.338 0,08 13,17 131.742 169.055.787
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 673 6,66 12,85 540 8.648
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.822.338 0,08 14,13 141.327 181.214.256
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.704 12.812.338 0,01 15,18 25.862 194.452.854
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.296 12.810.634 0,06 14,85 123.230 190.291.720
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 450 12.802.338 0,00 15,20 6.840 194.595.538
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.550 12.801.888 0,07 14,51 138.542 185.716.989
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.792.338 0,08 15,08 150.838 192.957.068
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.782.338 0,08 15,77 157.728 201.613.261
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4.550 12.772.338 0,04 15,65 71.218 199.915.189
2018-12-13 2018-12-11 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5.450 12.767.788 0,04 15,25 83.128 194.744.517
2018-12-10 2018-12-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.500 12.762.338 0,07 14,98 142.291 191.154.299
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 500 12.752.838 0,00 14,66 7.330 186.954.055
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.752.338 0,08 14,62 146.243 186.494.017
2018-12-04 2018-11-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2018-12-04 2018-11-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 631 6,77 13,40 536 8.455
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)